L. Brulhart

发表

Ultrasound evaluation of synovitis in RA: correlation with clinical disease activity and sensitivity to change in an observational cohort study.

P. Zufferey, A. Finckh, G. Tamborrini, 2014, Joint, bone, spine : revue du rhumatisme.

Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor α agents: an open-label observational study

C. Gabay, D. Kyburz, A. Finckh, 2006, Annals of the rheumatic diseases.

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

D. Courvoisier, U. Walker, C. Gabay, 2009, Annals of the rheumatic diseases.

Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: results of an observational cohort study.

P. Zufferey, A. Finckh, G. Tamborrini, 2014, Joint, bone, spine : revue du rhumatisme.

Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour

C. Gabay, J. Menetrey, A. Boucher, 2014, Annals of the rheumatic diseases.

The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis

D. Courvoisier, U. Walker, M. Mahler, 2017, Clinical Rheumatology.

Rituximab in the treatment of antisynthetase syndrome

C. Gabay, J. Waldburger, L. Brulhart, 2005, Annals of the rheumatic diseases.

OP0275 Persistence of ultrasound synovitis in the patients fullfiling the DAS and/or the new ACR/EULAR RA remission definitions: Results of the sonar score applied to the patients of the SCQM cohort

P. Zufferey, G. Tamborrini, A. Scherer, 2013 .

The importance of sonographer experience and machine quality with regards to the role of musculoskeletal ultrasound in routine care of rheumatoid arthritis patients.

P. Zufferey, G. Tamborrini, H. Ziswiler, 2015, Clinical and experimental rheumatology.

Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis

C. Gabay, I. Lazarou, P. Zufferey, 2019, RMD Open.

Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists.

C. Gabay, L. Brulhart, M. Nissen, 2010, Joint, bone, spine : revue du rhumatisme.

Does tenosynovitis of the hand detected by B-mode ultrasound predict loss of clinical remission in rheumatoid arthritis? Results from a real-life cohort

P. Zufferey, G. Tamborrini, R. Micheroli, 2022, Journal of ultrasonography.

Reproducibility and feasibility of a 22 joints ultrasound score in rheumatoid arthritis: a study among rheumatologists with diverse expertise in musculoskeletal ultrasound

T. Gerber, P. Zufferey, A. Krebs, 2011 .

B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.

C. Gabay, D. Kyburz, A. Finckh, 2007, Arthritis and rheumatism.

Greater trochanteric pain syndrome: predicting who will respond to a local glucocorticoid injection

D. Courvoisier, S. Genevay, A. Faundez, 2021, Scandinavian journal of rheumatology.

Glucocorticoid injections for greater trochanteric pain syndrome: a randomised double-blind placebo-controlled (GLUTEAL) trial

D. Courvoisier, S. Genevay, A. Faundez, 2018, Clinical Rheumatology.

Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab

D. Courvoisier, A. Finckh, D. Dan, 2021, RMD Open.

Angioinvasive aspergillosis mimicking giant cell arteritis in an 81-year-old man with jaw pain and vision loss

L. Brulhart, A. Pieren, Romain Guemara, 2022, RMD Open.

Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland

C. Gabay, P. Zufferey, D. Kyburz, 2020, RMD Open.

Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years

P. Mandl, D. Aletaha, P. Zufferey, 2019, Rheumatology.

Can Ultrasound Be Used to Predict Loss of Remission in Patients with RA in a Real-life Setting? A Multicenter Cohort Study

P. Zufferey, G. Tamborrini, A. Scherer, 2018, The Journal of Rheumatology.

Discordances between clinical and ultrasound measurements of disease activity among RA patients followed in real life.

M. D’Agostino, D. Courvoisier, P. Zufferey, 2019, Joint, bone, spine : revue du rhumatisme.

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor ( TNF ) agents after previous failure of an anti-TNF agent ?

A. Finckh, A. Ciurea, D. Kyburz, 2009 .

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

A. Finckh, A. Ciurea, D. Kyburz, 2009, Annals of the rheumatic diseases.